Takeda Chooses PRA To Lead Its Revamped Clinical Development Ops

Takeda has chosen US-based PRA Health Sciences to lead its clinical development as part of the Japanese drug maker’s global R&D overhaul aimed at cutting costs and improving efficiency and innovation.